HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Bernhard Selected Research

Clinical Deterioration

5/2006Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Bernhard Research Topics

Disease

6Neoplasms (Cancer)
01/2009 - 10/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 03/2011
1Lung Neoplasms (Lung Cancer)
02/2013
1Fatigue
02/2013
1Leukopenia
02/2013
1Neutropenia
02/2013
1Alopecia (Baldness)
02/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013
1Wounds and Injuries (Trauma)
04/2012
1Myeloid Leukemia (Leukemia, Myelocytic)
03/2011
1Leukemia
03/2011
1Thrombosis (Thrombus)
11/2010
1Atherosclerosis
11/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2009
1Disease Progression
10/2009
1Stroke (Strokes)
10/2009
1Carcinoma (Carcinomatosis)
01/2009
1Meningeal Carcinomatosis
05/2006
1Clinical Deterioration
05/2006
1Breast Neoplasms (Breast Cancer)
05/2006
1Neoplasm Metastasis (Metastasis)
05/2006
1Fever (Fevers)
08/2003
1Adenocarcinoma
08/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2003
1Melanoma (Melanoma, Malignant)
12/2002
1Neuroblastoma
12/2002
1Hepatitis B
10/2002
1Chronic Hepatitis B
10/2002
1Prostatic Neoplasms (Prostate Cancer)
03/2002
1Infections
07/2001

Drug/Important Bio-Agent (IBA)

7AntigensIBA
03/2011 - 10/2000
2Cisplatin (Platino)FDA LinkGeneric
02/2013 - 08/2003
2Docetaxel (Taxotere)FDA Link
02/2013 - 08/2003
2ThrombinFDA Link
11/2010 - 10/2009
2Peptides (Polypeptides)IBA
08/2001 - 10/2000
1Azacitidine (5 Azacytidine)FDA Link
01/2019
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2013
1PlasticsIBA
04/2012
1fms-Like Tyrosine Kinase 3IBA
03/2011
1Phosphotransferases (Kinase)IBA
03/2011
1Contraceptive Agents (Contraceptives)IBA
10/2009
1Oral ContraceptivesIBA
10/2009
1taxaneIBA
01/2009
1GemcitabineFDA Link
01/2009
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2009
1PlatinumIBA
01/2009
1Paclitaxel (Taxol)FDA LinkGeneric
01/2009
1Carboplatin (JM8)FDA LinkGeneric
01/2009
1Trastuzumab (Herceptin)FDA Link
05/2006
1Capecitabine (Xeloda)FDA Link
05/2006
1Methotrexate (Mexate)FDA LinkGeneric
05/2006
1Irinotecan (Camptosar)FDA LinkGeneric
08/2003
1GlycosphingolipidsIBA
12/2002
1GangliosidesIBA
12/2002
1CarbohydratesIBA
12/2002
1Interferon-gamma (Interferon, gamma)IBA
10/2002
1Antiviral Agents (Antivirals)IBA
10/2002
1Interleukin-12 (IL 12)IBA
10/2002
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
10/2002
1Proteins (Proteins, Gene)FDA Link
03/2002
1Cancer VaccinesIBA
03/2002
1Epidermal Growth Factor (EGF)IBA
01/2002
1human ERBB2 proteinIBA
08/2001
1DNA (Deoxyribonucleic Acid)IBA
07/2001
1HLA-A*02:01 antigenIBA
10/2000

Therapy/Procedure

3Therapeutics
01/2019 - 03/2002
1Aftercare (After-Treatment)
05/2006
1Radiotherapy
05/2006
1Immunotherapy
08/2001